0000885590-11-000017.txt : 20110411 0000885590-11-000017.hdr.sgml : 20110408 20110411152025 ACCESSION NUMBER: 0000885590-11-000017 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100928 FILED AS OF DATE: 20110411 DATE AS OF CHANGE: 20110411 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Provencio Norma Ann CENTRAL INDEX KEY: 0001343811 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 11752590 MAIL ADDRESS: STREET 1: 1041 WEST BADILLO STEET, SUITE 112 CITY: COVINA, CA STATE: CA ZIP: 91722 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 BUSINESS PHONE: 905 286-3000 MAIL ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4/A 1 primary_doc.xml PRIMARY DOCUMENT X0303 4/A 2010-09-28 2010-09-30 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001343811 Provencio Norma Ann C/O 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 1 0 0 0 Common Stock, no par value 2010-09-28 4 A 0 98930 0 A 98930 D Common Stock, no par value 2010-09-28 4 A 0 9051 0 A 107981 D Common Stock, no par value 2010-09-28 4 A 0 28795 0 A 136776 D Common Stock, no par value 2010-09-28 4 A 0 6233 0 A 143009 D Represents restricted share units received upon conversion of a portion of the reporting person's Valeant Pharmaceuticals International ("old Valeant") restricted stock units that were held prior to the merger between the issuer (formerly known as Biovail Corporation) and old Valeant (the "Merger"), in accordance with the terms of the merger agreement between the issuer and, amongst others, old Valeant. The restricted share units can be settled only in common shares of the issuer. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share. Represents common shares received upon conversion of the reporting person's remaining old Valeant restricted stock units that were held prior to the Merger (i.e. those that were not converted into restricted share units as described in Footnote 1), in accordance with the terms of the merger agreement. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share. Represents common shares held in the reporting person's 401k account and received in the Merger upon conversion of the reporting person's old Valeant common shares. This amendment is being filed to correct the number of common shares that were reported in the original filing. Represents common shares held in the reporting person's IRA and received in the Merger upon conversion of the reporting person's old Valeant common shares. By: Angie Palmer for Norma A. Provencio 2010-04-11